Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2128-35. doi: 10.1152/ajpheart.00107.2009. Epub 2009 Oct 9.

Abstract

Shear-induced platelet adhesion through the interaction of glycoprotein (GP) Ibalpha with von Willebrand factor (VWF) exposed at the injured vessel wall or atherosclerotic plaque rupture is a prerequisite for the physiological hemostatic process or pathological thrombus formation in stenosed arteries. Here we show that shear-induced interaction of platelets with immobilized VWF results in GPIbalpha ectodomain shedding. Washed platelets were exposed to VWF-coated glass capillary or cone-and-plate viscometer at different shear rates, and GPIbalpha ectodomain was shed from platelets, while a small mass of GPIbalpha COOH-terminal peptide, approximately 17 kDa, was increased correspondingly. The extent of GPIbalpha shedding was enhanced with the concentration of immobilized VWF and the time duration of constant shear stress, whereas it was obviously reduced with the decreased number of adherent platelets. Pretreatment of platelets with membrane-permeable calpain inhibitors and metalloproteinase inhibitor abolished shear-induced GPIbalpha shedding. Furthermore, GPIbalpha shedding was obviously diminished by anti-integrin-alphaIIbbeta3 monoclonal antibody SZ21, phosphatidylinositol 3-kinase inhibitor wortmannin, and cell-permeable calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid. These results indicate that shear-induced platelet-VWF interaction results in calpain and metalloproteinase-dependent GPIbalpha ectodomain shedding. These findings not only have a physiological implication in understanding the presence of glycocalicin in normal circulation, but also suggest a novel mechanism for the negative regulation of platelet function and the limitation of platelet thrombus infinite formation under pathophysiological flow conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Blood Platelets / drug effects
  • Blood Platelets / enzymology
  • Blood Platelets / metabolism*
  • Calpain / antagonists & inhibitors
  • Calpain / blood
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Membrane Glycoproteins / blood*
  • Metalloproteases / antagonists & inhibitors
  • Metalloproteases / blood
  • Phosphatidylinositol 3-Kinases / blood
  • Phosphoinositide-3 Kinase Inhibitors
  • Platelet Adhesiveness* / drug effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / immunology
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Platelet Glycoprotein GPIb-IX Complex
  • Protein Structure, Tertiary
  • Stress, Mechanical
  • Time Factors
  • von Willebrand Factor / metabolism*

Substances

  • Antibodies, Monoclonal
  • Enzyme Inhibitors
  • Membrane Glycoproteins
  • Phosphoinositide-3 Kinase Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Glycoprotein GPIb-IX Complex
  • adhesion receptor
  • von Willebrand Factor
  • Metalloproteases
  • Calpain